SUNY College of Optometry energized by first two phases of three-phase renovation, upgrade

Article

 

New York-David A. Heath, OD, EdM, president of the SUNY College of Optometry, announced the completion of the first two phases of a three-phase, $1.86-million renovation and upgrade of research laboratories and medical facilities at the State University of New York (SUNY) College of Optometry main building in Manhattan.

"The modernized laboratories will allow our faculty, post-doctoral scholars, and graduate students to continue the groundbreaking research efforts that have placed the SUNY College of Optometry among the leading vision research institutions in the country," said the college’s President, Dr. David A. Heath.

Kevin G. Harney, Stalco Construction principal, explained: “Phase I included a conversion of an old, 1,500-sq.-ft. laboratory space into two new research labs. The new facility features an easily modified, highly adaptable lab furniture system and utility connections that allow for floor plan revisions depending on the research needs. Phase II consisted of renovations and an expansion of an additional research area and faculty offices,” he added.

Joseph M. Serpe, Stalco vice president and project manager, said: “In the final third phase of the project, Stalco will build a new surgery suite, including surgery preparation, post-op, and procedure rooms as well as two bathrooms. The procedure room will feature surgical lighting and medical countertops and fixtures.”ODT

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.